Genomic Health's activity chart (see below) currently has 42 price targets and 23 ratings on display.
Analysts' price targets on this stock were met 77.5% of the time, taking 230.43 days on average.
Most recent stock forecast was given by MARK MASSARO from BTIG on 30-Jul-2019. First documented stock forecast 31-May-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2016
$72
$77
7 years 3 months 23 days ago
(30-Jul-2019)
5/8 (62.5%)
$-2 (-2.70%)
391
Buy Since 03-Jan-2019
$69
7 years 3 months 23 days ago
(30-Jul-2019)
2/4 (50%)
$14.75 (27.19%)
61
Sell Since 29-Jul-2019
$72
$25
7 years 3 months 24 days ago
(29-Jul-2019)
1/2 (50%)
$-1.07 (-1.46%)
7
Hold Since 11-Feb-2016
$72
$72
7 years 5 months 2 days ago
(20-Jun-2019)
4/5 (80%)
$16.88 (30.62%)
99
Buy Since 18-Jun-2013
$55
$38
7 years 5 months 23 days ago
(30-May-2019)
4/4 (100%)
$2 (3.77%)
841
What is GHDX (Genomic Health) average time for price targets to be met?
Which analyst most recently updated their price target on GHDX (Genomic Health)?
Which analyst has the lowest performance score on GHDX (Genomic Health) with a proven track record?
Which analyst has the most public recommendations on GHDX (Genomic Health)?
Which analyst is the currently most bullish on GHDX (Genomic Health)?
Which analyst is the currently most reserved on GHDX (Genomic Health)?